+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cyclic Peptides Market - Global Forecast 2026-2032- Product Image
Cyclic Peptides Market - Global Forecast 2026-2032- Product Image
New

Cyclic Peptides Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083542
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cyclic peptides market is seeing rapid advancement as new technologies and applications reshape its landscape. Senior executives require a focused, actionable overview to respond to changing regulatory frameworks, supply chain adjustments, and expanding cross-industry collaboration.

Market Snapshot: Cyclic Peptides Market Size and Growth

The cyclic peptides market continues its growth trajectory, increasing from USD 3.36 billion in 2025 to USD 3.57 billion in 2026, and projected to reach USD 5.27 billion by 2032 at a CAGR of 6.63%. This progress signals strong sector vitality, propelled by breakthroughs in biotechnological innovation and an expanding scope of applications in healthcare, diagnostics, and environmental sectors. Demand is increasing as enterprises pursue efficient drug development, targeted therapies, and advances in analytical methods. Companies and stakeholders are exploring opportunities in new treatment modalities and processes to capture emerging value across global markets.

Scope & Segmentation: In-Depth Market Coverage

This comprehensive report provides a detailed analysis of the cyclic peptides market, focusing on strategic levers—such as innovation, regulatory trends, and commercialization strategies—across the value chain. Segmentation ensures actionable intelligence for decision-makers evaluating growth pockets, technology adoption, and stakeholder roles worldwide.

  • Type: Natural cyclic peptides sourced from marine sponges, fungi, or plants; synthetic cyclic peptides engineered for optimized stability, enhanced selectivity, and longer half-life, enabling customizable therapeutic and diagnostic profiles.
  • Product Categories: Antimicrobial peptides; hormonal peptides for endocrine therapies; immunomodulating peptides; and peptide vaccines that enable next-generation immunization applications.
  • Technologies: Chemical synthesis through both solid-phase and liquid-phase methods; hybrid synthesis combining multiple techniques; use of recombinant DNA expression systems to allow scalable, high-fidelity production for research or commercial purposes.
  • Applications: Diagnostics including biosensors and immunoassays; environmental protection through pollutant sequestration; research and development for biochemical studies or drug discovery; and therapeutic use in cardiovascular, infectious, metabolic, or cancer indications.
  • End Users: Academic institutions driving fundamental research; biotechnology firms advancing innovation; and pharmaceutical companies engaged in discovery through product commercialization across the development pipeline.
  • Regions: Americas, Europe, Middle East, Africa, and Asia Pacific—each with unique investment climates, regulatory standards, and manufacturing capacity that shape regional opportunity and competitive landscape.

Cyclic Peptides Market: Key Takeaways and Strategic Insights

  • Broader recognition of cyclic peptides’ stability and specificity is accelerating their adoption in advanced therapeutic regimens and highly sensitive diagnostics.
  • Integration of hybrid and modular manufacturing techniques is enabling more rapid scaffold discovery and agile response to shifting market requirements.
  • Active collaborations among biopharmaceutical companies, research institutes, and contract manufacturers drive innovation, streamline product pipelines, and lower commercialization risks.
  • Increasing harmonization of regulatory approaches is reducing development timelines and supporting faster delivery of new peptide-based solutions to market.
  • Early adoption of artificial intelligence and platform-based development is improving selection efficiency, optimizing cost structures, and helping address unsolved clinical needs.

Tariff Impact: Supply Chain Realignment and Cost Pressures

With the introduction of U.S. tariffs on peptide intermediates in 2025, manufacturers are adapting by investing in domestic production, securing long-term supply contracts, and strengthening regional supply chains. These efforts are prompting capital outlays in North American synthesis infrastructure and encouraging diversified sourcing strategies to minimize cost impacts. Companies are increasingly adopting continuous manufacturing and modular facilities, enabling greater process agility and sustained cost management.

Research Methodology & Data Sources

Analysis is grounded in extensive primary and secondary research. Interviews with industry executives, scientists, and regulatory authorities underpin qualitative findings, while peer-reviewed literature, patent activity, and proprietary database insights reinforce data integrity. Multi-source triangulation and expert panel validation support rigorous, transparent results.

Why This Report Matters: Actionable Intelligence for Decision-Makers

  • Guides strategic investment decisions by thoroughly mapping changing supply chains, emerging manufacturing approaches, and evolving regulatory requirements.
  • Enables robust competitive planning through in-depth segmentation of market types, technologies, applications, and user profiles.
  • Prepares stakeholders to anticipate and respond to tariff-driven sourcing changes, ensuring long-term operational resilience.

Conclusion

The cyclic peptides market is shaped by advanced synthesis, global collaboration, and agile compliance strategies. Access to targeted insight empowers senior leaders to influence innovation pathways and achieve a decisive market position.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cyclic Peptides Market, by Type
8.1. Natural Cyclic Peptide
8.2. Synthetic Cyclic Peptide
9. Cyclic Peptides Market, by Product Type
9.1. Antimicrobial Peptides
9.1.1. Daptomycin
9.1.2. Gramicidin S
9.1.3. Tyrocidine
9.2. Hormonal Peptides
9.2.1. Oxytocin
9.2.2. Somatostatin
9.2.3. Vasopressin
9.3. Immunomodulating Peptides
9.4. Peptide Vaccines
10. Cyclic Peptides Market, by Technology
10.1. Chemical Synthesis
10.2. Liquid-Phase Synthesis
10.3. Recombinant DNA Technology
10.4. Solid-Phase Synthesis
11. Cyclic Peptides Market, by Application
11.1. Agriculture
11.2. Cosmetics
11.3. Diagnostics
11.3.1. Biosensors
11.3.2. Immunoassays
11.4. Research & Development
11.4.1. Biochemical Analysis
11.4.2. Drug Discovery
11.4.3. Molecular Biology
11.5. Therapeutics
11.5.1. Cardiovascular
11.5.2. Infectious Diseases
11.5.3. Metabolic Disorders
11.5.4. Oncology
12. Cyclic Peptides Market, by End User
12.1. Academic Institutes
12.2. Biotechnology Firms
12.3. Pharmaceutical Companies
13. Cyclic Peptides Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Cyclic Peptides Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cyclic Peptides Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Cyclic Peptides Market
17. China Cyclic Peptides Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AstraZeneca PLC
18.6. Aurigene Pharmaceutical Services by Dr. Reddy's Laboratories Ltd.
18.7. Bachem AG
18.8. Bicycle Therapeutics plc
18.9. BioDuro LLC
18.10. Biopharma PEG Scientific Inc
18.11. Biosynth Ltd.
18.12. Clariant AG
18.13. Corden Pharma International GmbH
18.14. CPC Scientific Inc.
18.15. Creative Peptides, Inc.
18.16. Eli Lilly and Company
18.17. Genscript Biotech Corporation
18.18. JPT Peptide Technologies GmbH
18.19. Kaneka Corporation
18.20. LifeTein LLC
18.21. Merck & Co., Inc.
18.22. Neuland Laboratories Ltd
18.23. Novartis AG
18.24. Pfizer Inc.
18.25. Sanofi S.A.
18.26. SciTide LLC
18.27. TCG Lifesciences Pvt. Ltd.
18.28. Thermo Fisher Scientific Inc.
18.29. Zealand Pharma A/S
List of Figures
FIGURE 1. GLOBAL CYCLIC PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CYCLIC PEPTIDES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CYCLIC PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CYCLIC PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CYCLIC PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY NATURAL CYCLIC PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY NATURAL CYCLIC PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY NATURAL CYCLIC PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY SYNTHETIC CYCLIC PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY SYNTHETIC CYCLIC PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY SYNTHETIC CYCLIC PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY DAPTOMYCIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY DAPTOMYCIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY DAPTOMYCIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY GRAMICIDIN S, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY GRAMICIDIN S, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY GRAMICIDIN S, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY TYROCIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY TYROCIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY TYROCIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY OXYTOCIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY OXYTOCIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY OXYTOCIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY SOMATOSTATIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY SOMATOSTATIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY SOMATOSTATIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY VASOPRESSIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY VASOPRESSIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY VASOPRESSIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY IMMUNOMODULATING PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY IMMUNOMODULATING PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY IMMUNOMODULATING PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY PEPTIDE VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY PEPTIDE VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY BIOSENSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY BIOSENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY MOLECULAR BIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY MOLECULAR BIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 160. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 161. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 165. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 166. EUROPE CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 180. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 182. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 183. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 184. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 186. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 187. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 188. AFRICA CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 203. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 205. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 206. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 207. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 209. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 210. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 211. ASEAN CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. GCC CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. GCC CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 214. GCC CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 215. GCC CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 216. GCC CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 217. GCC CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 218. GCC CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. GCC CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 220. GCC CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 221. GCC CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 222. GCC CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. BRICS CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. BRICS CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 236. BRICS CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. BRICS CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 238. BRICS CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 239. BRICS CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. BRICS CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. BRICS CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 242. BRICS CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 243. BRICS CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 244. BRICS CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. G7 CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. G7 CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 247. G7 CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 248. G7 CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 249. G7 CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 250. G7 CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. G7 CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. G7 CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 253. G7 CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 254. G7 CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 255. G7 CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. NATO CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 257. NATO CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 258. NATO CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 259. NATO CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 260. NATO CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 261. NATO CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 262. NATO CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. NATO CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 264. NATO CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 265. NATO CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 266. NATO CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL CYCLIC PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. CHINA CYCLIC PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 280. CHINA CYCLIC PEPTIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 281. CHINA CYCLIC PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 282. CHINA CYCLIC PEPTIDES MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 283. CHINA CYCLIC PEPTIDES MARKET SIZE, BY HORMONAL PEPTIDES, 2018-2032 (USD MILLION)
TABLE 284. CHINA CYCLIC PEPTIDES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 285. CHINA CYCLIC PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 286. CHINA CYCLIC PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 287. CHINA CYCLIC PEPTIDES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 288. CHINA CYCLIC PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 289. CHINA CYCLIC PEPTIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cyclic Peptides market report include:
  • Ajinomoto Bio-Pharma Services
  • Almac Group Ltd.
  • Alpha Biopharma, Inc.
  • AmbioPharm, Inc.
  • Amgen Inc.
  • Astellas Inc.
  • AstraZeneca PLC
  • Asymchem Inc.
  • Aurigene Pharmaceutical Services by Dr. Reddy's Laboratories Ltd.
  • Bachem AG
  • BCN Peptides GmbH
  • Bicycle Therapeutics plc
  • Bio Basic Inc.
  • BioDuro LLC
  • Biopeptek Pharmaceuticals Inc.
  • Biopharma PEG Scientific Inc
  • Biosynth Ltd.
  • Bristol-Myers Squibb Company
  • Clariant AG
  • Corden Pharma International GmbH
  • CPC Scientific Inc.
  • Creative Peptides, Inc.
  • CS Bio Co., Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Genscript Biotech Corporation
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • JPT Peptide Technologies GmbH
  • Kaneka Corporation
  • LifeTein LLC
  • Lonza Group Ltd.
  • Merck & Co., Inc.
  • Neuland Laboratories Ltd
  • Novartis AG
  • PeptiDream Inc.
  • Pfizer Inc.
  • Polypeptide Group AB
  • Provepharm Life Solutions SAS
  • Sanofi S.A.
  • ScinoPharm Taiwan Ltd.
  • SciTide LLC
  • Senn Chemicals AG
  • Space Peptides Pharmaceutical LLC
  • TCG Lifesciences Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec Co., Ltd.
  • Zealand Pharma A/S

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.57 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.27 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned49

Related Topics

Related Reports

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032 - Product Image

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
RGD Peptide Market - Global Forecast 2026-2032 - Product Image

RGD Peptide Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Report 2025 - Product Image

G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Antimicrobial Peptides Market - Global Strategic Business Report - Product Image

Antimicrobial Peptides Market - Global Strategic Business Report

  • Report
  • 471 Pages
  • Global
From
Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.